Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

Coordination and Support Action · Running

VALUEMAP Valuemap: Enabling Value-sharing and Adoption of Health Data Business Models

Coordinator
Eit Health Innostars eV, Germany
Runs
1 September 2026 to 29 February 2028
Status
Running
EU funding
€990k
Total cost
—
Partners
9 organisations in 6 countries
Type
Coordination and Support Action
Grant agreement
101304748

What the project is doing

In the project's own words, from its summary on CORDIS.

VALUEMAP accelerates adoption of EHDS-aligned, fair and sustainable business models for the secondary use of health data by turning fragmented practices into a shared, actionable European playbook. Led by EIT Health InnoStars with a multi-country, multi-stakeholder consortium, the project builds on an EIT Health Special Interest Group and targets more interconnected, inclusive and efficient health-data ecosystems. Phase 1 (Assess & Map) combines a European desk study, a pan-EU stakeholder survey, targeted interviews, five national multi-stakeholder roundtables, and an interregional synthesis workshop to distil opportunities, bottlenecks and key design choices across regions and actors.

Phase 2 (From evidence to action) establishes an Interregional Health Data Business Models Advisory Board to validate a prioritised set of recommendations, and co-designs two implementation-ready outputs: a multi-annual Joint Action Plan and a European collection of Best Practices & Toolkits (templates, model clauses, adoption roadmaps) that are locally adaptable yet interoperable across borders. Cross-cutting principles include inclusive participation (patients/citizens, SMEs, regional hospitals), GDPR-compliant data management, and structured synergies with EU flagship initiatives (e.g., TEHDAS2, DARWIN EU, EHDEN, HDABs, HealthData@EU) to align vocabulary, avoid duplication and speed reuse.

Expected results: a consensus-based plan and reusable toolkit enabling co-planning, co-implementation and co-investment; stronger links between innovators and authorities; and measurable uptake via an exploitation plan and early-adopter pathways—ultimately improving evidence generation, accelerating innovation and delivering better health outcomes.

Who is involved

OrganisationCityCountryRole
Eit Health Innostars eVMunchenGermanyCoordinator
Naucnoistrazivacki Institut Verlab Za Biomedicinski Inzinjering Medicinske Uredaje I Vjestacku InteligencijuSarajevoBosnia and HerzegovinaParticipant
Consejeria De Sanidad De La Comunidad De MadridMadridSpainParticipant
Fundacion Para La Investigacion E Innovacion Biosanitaria De Atencion PrimariaMadridSpainThird party
Fundacion Publica Andaluza Progreso Y Salud M.p.SevillaSpainParticipant
Institut Catala De La SalutBarcelonaSpainParticipant
Takeda Products Ireland LtdDublinIrelandAssociatedpartner
Associacao Colabtrials Laboratorio Colaborativo Para a Inovacao Em Ensaios ClinicosEvoraPortugalParticipant
Karolinska InstitutetStockholmSwedenParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI